Recall Register

Drug recall: Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC…

Class II FDA enforcement event 97716. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Acella Pharmaceuticals, LLC started this drug recall on 29 Sep 2025. The firm address in the FDA record is in Alpharetta, GA. FDA put the recall in Class II. FDA event 97716 has 1 product record. The first FDA enforcement report date is 15 Oct 2025. The record gives the status Ongoing. 115 of the 322 drug events that started in 2025 have more product records. The median drug event of 2025 has 1 product record. The openFDA file has 322 drug events that started in 2025 and 319 that started in 2024.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide in the USA

Recalling firm

Acella Pharmaceuticals, LLC, Alpharetta, GA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 97716: product records
Recall numberProductQuantityClassStatusReport date
D-0014-2026Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-501-05.4,680 500-count bottlesClass IIOngoing15 Oct 2025

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2025
322
Share of these events in Class II
79%
Product records in this event
1Median of the firm: 2
Events of the firm on the register
8

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 97716. https://recallregister.com/fda/ii/97716/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide in the USA
What quantity of product is in FDA event 97716?
The FDA record gives this quantity: 4,680 500-count bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2025 have the same class?
79% of the 322 drug events that started in 2025 are in Class II.